Antiangiogenic therapy for ocular diseases: Current status and challenges

Antiangiogenic therapy for ocular diseases: Current status and challenges

Abstract Angiogenesis is the process of new blood vessel growth from pre‐existing ones involving vascular endothelial cell activation, proliferation, migration, and tube formation. The vascular endothelial growth factor A (VEGF‐A) is known to be a key factor that promotes angiogenesis. Pathological...

Full description

Bibliographic Details
Main Authors: Rongyuan Chen, Juanhua Zhu, Jiaxin Hu, Xuri Li
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:MedComm – Future Medicine
Subjects:
angiogenesis
antiangiogenic therapy
anti‐VEGF‐A
ocular neovascular disease
Online Access:https://doi.org/10.1002/mef2.33

Internet

https://doi.org/10.1002/mef2.33

Similar Items